Recommendations on Trichological Treatments During COVID-19 Pandemic

June 2020 in “ Journal of Dermatological Treatment ”

Alfredo Rossi, Francesca Magri, Gemma Caro, Alessandro Federico, Marco Di Fraia, Marta Mellai, Maria Caterina Fortuna, Marta Carlesimo

trichological treatments SARS-CoV-2 chronic hair conditions scalp conditions telemedicine hygiene protocols hair treatments COVID-19 online consultations safety measures

TLDR Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

The paper examined the impact of SARS-CoV-2 on trichological treatments and provided guidelines for safely managing patients with chronic hair and scalp conditions during the COVID-19 pandemic. It emphasized the importance of minimizing in-person visits, utilizing telemedicine, and ensuring strict hygiene protocols to reduce the risk of virus transmission. The recommendations aimed to balance effective treatment with patient and healthcare provider safety.

View this study on iris.uniroma1.it →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy

47 citations , April 2020 in “Dermatologic Therapy”

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

research Platelet-Rich Plasma for Androgenetic Alopecia: A Review of the Literature and Proposed Treatment Protocol

45 citations , September 2018 in “International Journal of Women's Dermatology”

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

research An Investigation of Vitamin D Status in Alopecia Areata

37 citations , June 2018 in “Clinical and Experimental Medicine”

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

research A Preliminary Study on Topical Cetirizine in the Therapeutic Management of Androgenetic Alopecia

21 citations , June 2017 in “Journal of Dermatological Treatment”

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

research Comparative Effectiveness of Finasteride vs Serenoa Repens in Male Androgenetic Alopecia: A Two-Year Study

51 citations , October 2012 in “International Journal of Immunopathology and Pharmacology”

Finasteride works better than Serenoa repens for male hair loss.

research Minoxidil Use in Dermatology, Side Effects, and Recent Patents

152 citations , April 2012 in “Recent Patents on Inflammation & Allergy Drug Discovery”

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

research Melatonin and the Hair Follicle

109 citations , October 2007 in “Journal of pineal research”

Melatonin helps regulate hair growth and protects the hair follicle from stress.

research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor

408 citations , May 2004 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Melatonin Increases Anagen Hair Rate in Women With Androgenetic Alopecia or Diffuse Alopecia: Results of a Pilot Randomized Controlled Trial

research Melatonin Increases Anagen Hair Rate in Women With Androgenetic Alopecia or Diffuse Alopecia: Results of a Pilot Randomized Controlled Trial

78 citations , February 2004 in “British Journal of Dermatology”

Melatonin helps hair growth in women with hair loss.

Similar Research

5 / 292 results

research Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence

February 2025 in “Healthcare”

Caffeine may help with hair loss, but more research is needed.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research COVID-19-Induced Hair Shedding and Related Risk Factors: A Saudi Perspective

December 2023 in “Journal of family medicine and primary care”

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

research Telogen Effluvium Following COVID-19 Infection: A Retrospective Study of 113 Cases

January 2025 in “International Journal of Trichology”

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

research Assessment of Selective Elements in Serum and Hair Samples of Women with Post-COVID-19 Alopecia: Copper Significance

June 2024 in “Research Square (Research Square)”

Copper deficiency is linked to post-COVID-19 hair loss in women.